Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
David B. Beck, Marcela A. Ferrada, Keith A. Sikora, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 27, pp. 2628-2638
Open Access | Times Cited: 823

Showing 1-25 of 823 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1703-1719
Open Access | Times Cited: 2445
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1596
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
Stuart G. Tangye, Waleed Al‐Herz, Aziz Bousfiha, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 7, pp. 1473-1507
Open Access | Times Cited: 818
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 564-574
Open Access | Times Cited: 284
Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases
Gustaf Wigerblad, Mariana J. Kaplan
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 274-288
Open Access | Times Cited: 236
Therapeutic options in VEXAS syndrome: insights from a retrospective series
Estelle Bourbon, Maël Heiblig, Mathieu Gerfaud Valentin, et al.
Blood (2021) Vol. 137, Iss. 26, pp. 3682-3684
Open Access | Times Cited: 220
The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee
Stuart G. Tangye, Waleed Al‐Herz, Aziz Bousfiha, et al.
Journal of Clinical Immunology (2021) Vol. 41, Iss. 3, pp. 666-679
Open Access | Times Cited: 196
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis
Maya H Buch, Stephen Eyre, Dennis McGonagle
Nature Reviews Rheumatology (2020) Vol. 17, Iss. 1, pp. 17-33
Closed Access | Times Cited: 187
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
Marcela A. Ferrada, Keith A. Sikora, Yiming Luo, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 10, pp. 1886-1895
Closed Access | Times Cited: 181
Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
James A. Poulter, Jason C. Collins, Catherine Cargo, et al.
Blood (2021) Vol. 137, Iss. 26, pp. 3676-3681
Open Access | Times Cited: 177
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1
Ifeyinwa E. Obiorah, Bhavisha A. Patel, Emma M. Groarke, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3203-3215
Open Access | Times Cited: 168
Juvenile idiopathic arthritis
Alberto Martini, Daniel J. Lovell, Salvatore Albani, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 168
Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS
Caspar I. van der Made, Judith Potjewijd, Annemiek Hoogstins, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 1, pp. 432-439.e4
Open Access | Times Cited: 162
Somatic Mutations in “Benign” Disease
Satu Mustjoki, Neal S. Young
New England Journal of Medicine (2021) Vol. 384, Iss. 21, pp. 2039-2052
Closed Access | Times Cited: 145
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster, et al.
Blood (2022) Vol. 140, Iss. 8, pp. 927-931
Open Access | Times Cited: 142
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population
David B. Beck, Dale L. Bodian, Vandan Shah, et al.
JAMA (2023) Vol. 329, Iss. 4, pp. 318-318
Open Access | Times Cited: 134
Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
Thibault Comont, Maël Heiblig, Étienne Rivière, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 969-974
Open Access | Times Cited: 121
Gene–environment interactions and their impact on human health
Samuel J. Virolainen, Andrew VonHandorf, Kenyatta C. M. F. Viel, et al.
Genes and Immunity (2022) Vol. 24, Iss. 1, pp. 1-11
Open Access | Times Cited: 120
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience
Ava Diarra, Nicolas Duployez, Élise Fournier, et al.
Blood Advances (2021) Vol. 6, Iss. 3, pp. 998-1003
Open Access | Times Cited: 116
Nursing homes during the COVID-19 pandemic: a scoping review of challenges and responses
Shamik Giri, Lee Minn Chenn, Román Romero‐Ortuño
European Geriatric Medicine (2021) Vol. 12, Iss. 6, pp. 1127-1136
Open Access | Times Cited: 111
Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis
Naomi Tsuchida, Yosuke Kunishita, Yuri Uchiyama, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 8, pp. 1057-1061
Closed Access | Times Cited: 110
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis
Marcela A. Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1496-1506
Open Access | Times Cited: 101
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 2, pp. 106-117
Open Access | Times Cited: 92
Disorders of ubiquitylation: unchained inflammation
David B. Beck, Achim Werner, Daniel L. Kastner, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 8, pp. 435-447
Open Access | Times Cited: 75
ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling
Matteo Gentili, Bingxu Liu, Malvina Papanastasiou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top